Pharmaceutical manufacturing relies heavily on the consistent availability and high quality of its raw materials and intermediates. Pyrrolo[2,3-d]pyrimidin-4-ol (CAS: 3680-71-5) is one such critical compound, serving as a vital intermediate in the synthesis of numerous advanced pharmaceutical products, particularly in the oncology and immunology sectors.

As a dedicated chemical manufacturer and supplier, we focus on providing Pyrrolo[2,3-d]pyrimidin-4-ol to meet the stringent demands of the pharmaceutical industry. The significance of this molecule stems from its application in the production of targeted therapies like tofacitinib, a widely used medication for autoimmune diseases. For manufacturers aiming to buy this essential intermediate, understanding its specifications—including a typical purity of >98% by HPLC and its appearance as a white to off-white solid powder—is crucial for ensuring the quality and efficacy of the final drug. Sourcing directly from a reliable manufacturer, especially one based in China, can offer considerable advantages in terms of cost and supply chain stability.

When selecting a supplier for Pyrrolo[2,3-d]pyrimidin-4-ol, factors such as batch consistency, regulatory compliance, and the ability to scale production are paramount. A strong supplier will provide comprehensive documentation, including Certificates of Analysis (CoA), and demonstrate robust quality control processes. Whether you are involved in early-stage R&D or large-scale commercial manufacturing, securing a dependable source for this intermediate is fundamental. We pride ourselves on being that dependable source, offering competitive pricing and expert support to facilitate your manufacturing goals.